vs
Hilltop Holdings Inc.（HTH）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Hilltop Holdings Inc.的季度营收约是REPLIGEN CORP的1.5倍（$300.5M vs $197.9M），Hilltop Holdings Inc.净利率更高（13.0% vs 6.7%，领先6.3%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 0.6%）
Hilltop Holdings Inc.是总部位于美国得克萨斯州达拉斯的金融控股公司，旗下拥有PlainsCapital Bank、PrimeLending与HilltopSecurities三大核心子公司，为客户提供多元金融产品及银行相关服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
HTH vs RGEN — 直观对比
营收规模更大
HTH
是对方的1.5倍
$197.9M
净利率更高
HTH
高出6.3%
6.7%
两年增速更快
RGEN
近两年复合增速
0.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $300.5M | $197.9M |
| 净利润 | $39.0M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 13.0% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | -12.4% | 143.9% |
| 每股收益（稀释后） | $0.64 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HTHRGEN
| Q1 26 | $300.5M | — | ||
| Q4 25 | $329.9M | $197.9M | ||
| Q3 25 | $330.2M | $188.8M | ||
| Q2 25 | $303.3M | $182.4M | ||
| Q1 25 | $318.5M | $169.2M | ||
| Q4 24 | $301.1M | $174.1M | ||
| Q3 24 | $305.5M | $154.9M | ||
| Q2 24 | $297.0M | $154.1M |
净利润HTHRGEN
| Q1 26 | $39.0M | — | ||
| Q4 25 | $41.6M | $13.3M | ||
| Q3 25 | $45.8M | $14.9M | ||
| Q2 25 | $36.1M | $14.9M | ||
| Q1 25 | $42.1M | $5.8M | ||
| Q4 24 | $35.5M | $-30.3M | ||
| Q3 24 | $29.7M | $-654.0K | ||
| Q2 24 | $20.3M | $3.3M |
毛利率HTHRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率HTHRGEN
| Q1 26 | — | — | ||
| Q4 25 | 16.1% | 9.0% | ||
| Q3 25 | 18.4% | 8.9% | ||
| Q2 25 | 16.3% | 7.6% | ||
| Q1 25 | 18.1% | 3.9% | ||
| Q4 24 | 14.7% | -17.7% | ||
| Q3 24 | 13.9% | -5.1% | ||
| Q2 24 | 10.0% | 1.0% |
净利率HTHRGEN
| Q1 26 | 13.0% | — | ||
| Q4 25 | 12.6% | 6.7% | ||
| Q3 25 | 13.9% | 7.9% | ||
| Q2 25 | 11.9% | 8.2% | ||
| Q1 25 | 13.2% | 3.4% | ||
| Q4 24 | 11.8% | -17.4% | ||
| Q3 24 | 9.7% | -0.4% | ||
| Q2 24 | 6.8% | 2.2% |
每股收益（稀释后）HTHRGEN
| Q1 26 | $0.64 | — | ||
| Q4 25 | $0.68 | $0.24 | ||
| Q3 25 | $0.74 | $0.26 | ||
| Q2 25 | $0.57 | $0.26 | ||
| Q1 25 | $0.65 | $0.10 | ||
| Q4 24 | $0.55 | $-0.55 | ||
| Q3 24 | $0.46 | $-0.01 | ||
| Q2 24 | $0.31 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | $990.8M | $542.2M |
| 股东权益账面价值 | $2.2B | $2.1B |
| 总资产 | $15.7B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.46× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资HTHRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务HTHRGEN
| Q1 26 | $990.8M | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益HTHRGEN
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.2B | $2.1B | ||
| Q3 25 | $2.2B | $2.1B | ||
| Q2 25 | $2.2B | $2.1B | ||
| Q1 25 | $2.2B | $2.0B | ||
| Q4 24 | $2.2B | $2.0B | ||
| Q3 24 | $2.2B | $2.0B | ||
| Q2 24 | $2.1B | $2.0B |
总资产HTHRGEN
| Q1 26 | $15.7B | — | ||
| Q4 25 | $15.8B | $2.9B | ||
| Q3 25 | $15.6B | $2.9B | ||
| Q2 25 | $15.4B | $2.9B | ||
| Q1 25 | $15.8B | $2.9B | ||
| Q4 24 | $16.3B | $2.8B | ||
| Q3 24 | $15.9B | $2.8B | ||
| Q2 24 | $15.6B | $2.9B |
负债/权益比HTHRGEN
| Q1 26 | 0.46× | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流HTHRGEN
| Q1 26 | — | — | ||
| Q4 25 | $-38.7M | $25.7M | ||
| Q3 25 | $273.0M | $48.1M | ||
| Q2 25 | $-234.6M | $28.6M | ||
| Q1 25 | $5.8M | $15.0M | ||
| Q4 24 | $273.9M | $39.2M | ||
| Q3 24 | $515.6M | $49.3M | ||
| Q2 24 | $-435.3M | $42.2M |
自由现金流HTHRGEN
| Q1 26 | — | — | ||
| Q4 25 | $-55.5M | $17.6M | ||
| Q3 25 | $271.0M | $43.4M | ||
| Q2 25 | $-234.6M | $21.5M | ||
| Q1 25 | $5.0M | $11.4M | ||
| Q4 24 | $266.8M | $33.6M | ||
| Q3 24 | $513.8M | $42.3M | ||
| Q2 24 | $-437.3M | $37.4M |
自由现金流率HTHRGEN
| Q1 26 | — | — | ||
| Q4 25 | -16.8% | 8.9% | ||
| Q3 25 | 82.1% | 23.0% | ||
| Q2 25 | -77.4% | 11.8% | ||
| Q1 25 | 1.6% | 6.8% | ||
| Q4 24 | 88.6% | 19.3% | ||
| Q3 24 | 168.2% | 27.3% | ||
| Q2 24 | -147.2% | 24.3% |
资本支出强度HTHRGEN
| Q1 26 | — | — | ||
| Q4 25 | 5.1% | 4.1% | ||
| Q3 25 | 0.6% | 2.5% | ||
| Q2 25 | 0.0% | 3.9% | ||
| Q1 25 | 0.3% | 2.1% | ||
| Q4 24 | 2.4% | 3.2% | ||
| Q3 24 | 0.6% | 4.5% | ||
| Q2 24 | 0.7% | 3.1% |
现金转化率HTHRGEN
| Q1 26 | — | — | ||
| Q4 25 | -0.93× | 1.93× | ||
| Q3 25 | 5.96× | 3.23× | ||
| Q2 25 | -6.50× | 1.92× | ||
| Q1 25 | 0.14× | 2.57× | ||
| Q4 24 | 7.71× | — | ||
| Q3 24 | 17.36× | — | ||
| Q2 24 | -21.41× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HTH
| Noninterest Income | $188.4M | 63% |
| Net Interest Income | $112.1M | 37% |
RGEN
暂无分部数据
